CX-691

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
CX-516, an AMPA modulator from Cortex Pharmaceuticals, is in phase I/IIa clinical trials for the symptomatic treatment of… (More)
Is this relevant?